Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Innovation /
      What is cardiac ablation?
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

      Share Article
      share to

      Fluctuations in your heartbeat can be normal—say, when you’re exercising or sleeping. But certain heart conditions, including atrial fibrillation (AFib), cause irregular heartbeats (otherwise known as arrhythmias) that aren’t normal. And if left untreated, arrhythmias can lead to cardiac arrest, heart failure or stroke.

      Cardiac ablation is a minimally invasive surgical procedure that uses heat or cold energy to destroy a small area of heart tissue that is causing those arrhythmias. The goal is to block irregular electrical signals and restore the heart’s regular rhythm.

      “Medications may sometimes be effective but are associated with long-term side effects and risks,” explains Brett Gidney, M.D., an electrophysiologist at UCLA Health. “Most patients would choose an ablation procedure if they have access to a cardiac electrophysiologist.” In fact, a study published in a 2023 issue of Heart Rhythm O2 found that patients who underwent cardiac ablation had a 57% lower risk of developing heart failure than those receiving anti-arrhythmic drugs.

      How the procedure works

      With cardiac ablation, sometimes called catheter ablation, a small flexible tube (a.k.a. catheter) is inserted into a vein in the groin and guided through the veins and/or arteries up into the heart. There, the location of the abnormal tissue that’s responsible for the arrhythmia is identified.

      Biosense Webster’s CARTO 3D Mapping System allows electrophysiologists to identify the abnormal tissue by generating a 3D electroanatomic map of the heart chambers and navigate safely around them in real time.

      Biosense Webster's Carto 3D cardiac mapping technology

      The CARTO PRIME® Module offers advancement in 3D mapping technology.

      “Integrated mapping has been a cornerstone of cardiac ablation over the years because it can help identify appropriate treatment pathways to tailor the procedure to each patient,” says Anthony Hong, Vice President, Global Strategic Marketing, at Biosense Webster, a Johnson & Johnson MedTech company.

      Once the problem area is identified, the abnormal heart tissue is destroyed using either radiofrequency ablation (extreme heat) or cryoablation (extreme cold). The resulting scar tissue blocks the abnormal electrical signals and restores a normal heartbeat.

      Choosing whether to use radiofrequency ablation or cryoablation depends on a number of factors, including the specific characteristics of a patient’s AFib, the availability of the technologies and the preferences and experience level of the electrophysiologist, says Dr. Gidney. Research shows that, overall, the two procedures are comparable in their effectiveness.

      The healing and recovery process is very easy, and most people are back to their normal activities within 48 hours.
      Brett Gidney, M.D.,
      Electrophysiologist at UCLA Health

      Dr. Gidney explains that cardiac ablation procedures typically take 30 minutes to two hours, and most patients are able to go home the same day. “The healing and recovery process is very easy, and most people are back to their normal activities within 48 hours.”

      Currently in clinical development at Biosense Webster is Pulsed Field Ablation (PFA) technology, which uses a controlled electric field to ablate cardiac tissue. PFA has the potential to offer safe, consistent and efficient therapy for patients. Because the energy does not rely on thermal effects to destroy targeted tissue, PFA offers the potential to minimize injury to the surrounding tissue. Among the potential benefits for both patients and physicians: PFA shaves time off the procedure and potentially reduces the risk of damage to the esophagus, veins and nerves that exists with other ablation techniques.

      Living with AFib?

      Learn more about treatments for irregular heartbeat.

      More from Johnson & Johnson

      Latest news
      healthcare worker in protective medical gear

      Johnson & Johnson named to Fortune’s 2024 America’s Most Innovative Companies list

      The company’s drive to develop novel solutions for the world’s toughest healthcare challenges has earned it a spot on Fortune’s second annual list.
      Innovation
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      Innovation
      Close-up of a woman with low vision receiving an eye exam exam with a doctor shining light into her left eye

      What is low vision?

      Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. For Low Vision Awareness Month, learn the facts—plus, the promising treatment innovations that are in the works.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.